Ovarian cancer: Difference between revisions
No edit summary |
|||
| Line 32: | Line 32: | ||
==[[Ovarian cancer natural history|Natural History, Complications, and Prognosis]]== | ==[[Ovarian cancer natural history|Natural History, Complications, and Prognosis]]== | ||
==Diagnosis== | |||
[[Ovarian cancer history and symptoms|History and Symptoms]] | [[Ovarian cancer physical examination|Physical Examination]] | [[Ovarian cancer staging|Staging]] | [[Ovarian cancer laboratory tests|Laboratory tests]] | [[Ovarian cancer electrocardiogram|Electrocardiogram]] | [[Ovarian cancer x ray|X Rays]] | [[Ovarian cancer CT|CT]] | [[Ovarian cancer MRI|MRI]] [[Ovarian cancer echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Ovarian cancer other imaging findings|Other images]] | [[Ovarian cancer other diagnostic studies|Alternative diagnostics]] | |||
==Treatment== | |||
[[Ovarian cancer medical therapy|Medical therapy]] | [[Ovarian cancer surgery|Surgical options]] | [[Ovarian cancer primary prevention|Primary prevention]] | [[Ovarian cancer secondary prevention|Secondary prevention]] | [[Ovarian cancer cost-effectiveness of therapy|Financial costs]] | [[Ovarian cancer future or investigational therapies|Future therapies]] | |||
==Staging== | ==Staging== | ||
Revision as of 20:48, 17 January 2012
For patient information click here. Template:DiseaseDisorder infobox
|
Ovarian cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian cancer On the Web |
|
American Roentgen Ray Society Images of Ovarian cancer |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Pathophysiology
Classifications
Epidemiology and Demographics
Risk Factors
Screening
Causes
Differentiating Ovarian cancer from other Disorders
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
Staging
Ovarian cancer staging is by the FIGO staging system and uses information obtained after surgery, which can include a total abdominal hysterectomy, removal of (usually) both ovaries and fallopian tubes, (usually) the omentum, and pelvic (peritoneal) washings for cytology. The American Joint Committee on Cancer (AJCC) stage is the same as the FIGO stage.
- Stage I - limited to one or both ovaries
- IA - involves one ovary; capsule intact; no tumor on ovarian surface; no malignant cells in ascites or peritoneal washings
- IB - involves both ovaries; capsule intact; no tumor on ovarian surface; negative washings
- IC - tumor limited to ovaries with any of the following: capsule ruptured, tumor on ovarian surface, positive washings
- Stage II - pelvic extension or implants
- IIA - extension or implants onto uterus or fallopian tube; negative washings
- IIB - extension or implants onto other pelvic structures; negative washings
- IIC - pelvic extension or implants with positive peritoneal washings
- Stage III - microscopic peritoneal implants outside of the pelvis; or limited to the pelvis with extension to the small bowel or omentum
- IIIA - microscopic peritoneal metastases beyond pelvis
- IIIB - macroscopic peritoneal metastases beyond pelvis less than 2 cm in size
- IIIC - peritoneal metastases beyond pelvis > 2 cm or lymph node metastases
- Stage IV - distant metastases--in the liver, or outside the peritoneal cavity
Para-aortic lymph node metastases are considered regional lymph nodes (Stage IIIC).
Diagnosis
History and Symptoms | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X Ray | MRI | CT | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical: Medical Therapy
Surgical: Surgery
Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies